These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15914125)

  • 1. Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53.
    Rosner D; McCarthy N; Bennett M
    Cardiovasc Res; 2005 Jun; 66(3):601-10. PubMed ID: 15914125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR and P70 S6 kinase expression in primary liver neoplasms.
    Sahin F; Kannangai R; Adegbola O; Wang J; Su G; Torbenson M
    Clin Cancer Res; 2004 Dec; 10(24):8421-5. PubMed ID: 15623621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
    Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
    Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
    Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
    Walcher D; Babiak C; Poletek P; Rosenkranz S; Bach H; Betz S; Durst R; Grüb M; Hombach V; Strong J; Marx N
    Circ Res; 2006 Nov; 99(11):1181-7. PubMed ID: 17068290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells.
    Adkins JR; Castresana MR; Wang Z; Newman WH
    Am Surg; 2004 May; 70(5):384-7; discussion 387-8. PubMed ID: 15156944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design.
    Steffel J; Latini RA; Akhmedov A; Zimmermann D; Zimmerling P; Lüscher TF; Tanner FC
    Circulation; 2005 Sep; 112(13):2002-11. PubMed ID: 16172265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog signaling induces vascular smooth muscle cell proliferation via induction of the G1 cyclin-retinoblastoma axis.
    Li F; Duman-Scheel M; Yang D; Du W; Zhang J; Zhao C; Qin L; Xin S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1787-94. PubMed ID: 20720195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells.
    Wassmann S; Wassmann K; Jung A; Velten M; Knuefermann P; Petoumenos V; Becher U; Werner C; Mueller C; Nickenig G
    J Mol Cell Cardiol; 2007 Sep; 43(3):301-7. PubMed ID: 17659301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer.
    Nozawa H; Watanabe T; Nagawa H
    Cancer Lett; 2007 Jun; 251(1):105-13. PubMed ID: 17175097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts.
    Gao A; Liu B; Shi X; Jia X; Ye M; Jiao S; You B; Huang C
    Toxicol Lett; 2007 Apr; 170(1):30-41. PubMed ID: 17383120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antirestenotic mechanisms of everolimus on human coronary artery smooth muscle cells: inhibition of human coronary artery smooth muscle cell proliferation, but not migration.
    Lavigne MC; Grimsby JL; Eppihimer MJ
    J Cardiovasc Pharmacol; 2012 Feb; 59(2):165-74. PubMed ID: 21983747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors.
    Drayer AL; Olthof SG; Vellenga E
    Stem Cells; 2006 Jan; 24(1):105-14. PubMed ID: 16123382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression.
    Son DJ; Ha SJ; Song HS; Lim Y; Yun YP; Lee JW; Moon DC; Park YH; Park BS; Song MJ; Hong JT
    J Pharmacol Exp Ther; 2006 May; 317(2):627-34. PubMed ID: 16401728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic strain amplitude dictates the growth response of vascular smooth muscle cells in vitro: role in in-stent restenosis and inhibition with a sirolimus drug-eluting stent.
    Colombo A; Guha S; Mackle JN; Cahill PA; Lally C
    Biomech Model Mechanobiol; 2013 Aug; 12(4):671-83. PubMed ID: 22961302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation.
    Giordano A; Romano S; Mallardo M; D'Angelillo A; Calì G; Corcione N; Ferraro P; Romano MF
    Cardiovasc Res; 2008 Aug; 79(3):519-26. PubMed ID: 18349138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.